| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
| 02/09/2006 | US20060030605 Pharmaceutical compounds |
| 02/09/2006 | US20060030604 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 02/09/2006 | US20060030592 I-Oxo- and 1,3-dioxoisoindolines and method of reducing inflammatory cytokine levels |
| 02/09/2006 | US20060030576 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |
| 02/09/2006 | US20060030560 Pyrimidine compounds |
| 02/09/2006 | US20060030546 antiallergen, viricide, herbicide, autoimmune diseases; screening procedure for the identification of enzymes GcpE and LytB inhibitor; 4-hydroxy-3-methyl-2-butenyl 1-pyrophosphate; precursor of higher isoprenoids in 2-methyl-D-erythritol pathway (MEP) |
| 02/09/2006 | US20060030540 Transgenic animals produced using oral administration of a genetic agent coupled to a transporting agent |
| 02/09/2006 | US20060030532 Directly contacting bacteria or fungi, especially Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Proteus vulgaris, Enterococcus faecalis, or Candida albicans, with a substance P analog |
| 02/09/2006 | US20060030048 Plasmid maintenance system for antigen delivery |
| 02/09/2006 | US20060030047 Plasmid maintenance system for antigen delivery |
| 02/09/2006 | US20060029990 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1 immunoreactivity |
| 02/09/2006 | US20060029928 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (prrsv), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a prrsv and a method of detecting a |
| 02/09/2006 | US20060029689 Skin protection composition |
| 02/09/2006 | US20060029684 Synergistic treatment of DNA viral infections |
| 02/09/2006 | US20060029677 Azithromycin dosage forms with reduced side effects |
| 02/09/2006 | US20060029623 Invert emulsions comprising at least one active agent sensitive to water and cosmetic/dermatological applications thereof |
| 02/09/2006 | US20060029621 Vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis |
| 02/09/2006 | US20060029619 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter |
| 02/09/2006 | US20060029616 live vector vaccine; removal of sole dependence on catalytic balanced lethal maintenance systems; plasmid partition system prevents random segregation; enhanced inheritance and stability; genetic engineering; antibiotic resistance |
| 02/09/2006 | US20060029615 Novel recombinant T4 phage particle and uses thereof |
| 02/09/2006 | US20060029596 Administering to the tumor an adenovirus vector, overexpresses an adenovirus death protein; promoting the death of neoplastic cells; telomerase resistance; anticancer biodrugs |
| 02/09/2006 | US20060029572 Administering interferon-beta (IFN- beta 9), after failed treatment with interferon- alpha |
| 02/09/2006 | US20060029569 Water-in-oil emulsions with anionic groups, compositions, and methods |
| 02/09/2006 | US20060029568 Anionic polymers as toxin binders and antibacterial agents |
| 02/09/2006 | DE102004034613A1 Use of condensation products produced by reacting aromatic compound with sulfonating agent and carbonyl compound followed by molecular size-dependent separation as medicaments useful for treating e.g. herpes simplex infections |
| 02/08/2006 | EP1623717A1 Composition against infection with rotavirus and process for producing the same |
| 02/08/2006 | EP1623714A2 Treatment kit which assists with antibiotic therapy for intracellular infectious diseases |
| 02/08/2006 | EP1623028A1 Crystal structure of human coronavirus 229e main proteinase, and uses thereof for developing sars inhibitors |
| 02/08/2006 | EP1622913A1 Heterocyclic compounds for use in the treatment of viral infections |
| 02/08/2006 | EP1622890A2 Blockers of the quorum sensing system of gram-negative bacteria |
| 02/08/2006 | EP1622880A1 Substituted dihydrochinazolines having antiviral properties |
| 02/08/2006 | EP1622643A2 Avian combination-vaccine against e. coli and salmonella |
| 02/08/2006 | EP1622641A2 Vaccinating against infectious diseases using proteosomes |
| 02/08/2006 | EP1478393A4 Anti-pathogen treatements |
| 02/08/2006 | EP1358162B1 Dihydroindole and tetrahydroquinoline derivatives |
| 02/08/2006 | EP1352052B1 Method for preparing submicron particle suspensions of pharmaceutical agents |
| 02/08/2006 | EP1318978B1 N-acylsulfonamide apoptosis promoters |
| 02/08/2006 | EP1297006B1 Regulation of human prostasin-like serine protease |
| 02/08/2006 | EP1226176B1 Production of mammary secretion antibodies in farm animals |
| 02/08/2006 | EP1119362B1 Use of tetracycline derivatives to enhance interleukin-10 production |
| 02/08/2006 | EP1112362B1 GENE MODIFICATION IN THE GENE FOR THE DIE G$g(b)3-SUB-UNIT OF HUMAN G-PROTEIN |
| 02/08/2006 | EP1068297B1 Use of monocytes derived cells, antigens and antibodies for optimal induction of immunotherapeutic efficiency |
| 02/08/2006 | EP1007657B1 Hiv-specific oligonucleotides and methods of their use |
| 02/08/2006 | EP0932600B1 Sulfonamide substituted aspartic acid interleukin-1beta converting enzyme inhibitors |
| 02/08/2006 | CN1732165A 1-acyl-pyrrolidine derivatives for the treatment of viral infections |
| 02/08/2006 | CN1732147A Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 02/08/2006 | CN1731993A Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 02/08/2006 | CN1730654A Antisense oligonucleotide sequence resistant to Candida albicans infection and its uses |
| 02/08/2006 | CN1730491A Cat omega interferon and its coding gene and uses |
| 02/08/2006 | CN1730448A Cimicifuga rhizome organic acid extraction method and novel uses |
| 02/08/2006 | CN1730080A Medicine for treating AIDS |
| 02/08/2006 | CN1730054A Medicine for treating asymptomatic HBeAg positive chronic hepatitis B |
| 02/08/2006 | CN1730027A Method for preparing anti-hepatitis active part from swertia main pharmaceutical plant |
| 02/08/2006 | CN1730023A Hepatitis virus resistant Chinese medicinal formulation and method for preparing same |
| 02/08/2006 | CN1730015A Honey suckle extract and its preparing process and application |
| 02/08/2006 | CN1729996A Process for preparing high-immune serum for main epidemic disease of dog and formulation thereof |
| 02/08/2006 | CN1729993A Externally applied bath liquid for epidemic wind-heat type cold |
| 02/08/2006 | CN1729992A Externally applied bath liquid for epidemic wind-cold type cold |
| 02/08/2006 | CN1729991A Dripping pills of tripterigium wilfordi glycosides and its preparation process |
| 02/08/2006 | CN1729990A Dripping pills of diosgenin and its preparation process |
| 02/08/2006 | CN1729987A Cefuroxime sodium and sulbactam sodium composition for injection |
| 02/08/2006 | CN1729983A Pharmaceutical composition of cefadroxil and ª‰-lactamase inhibitor |
| 02/08/2006 | CN1729979A Soft capsule of fibrauretine composition |
| 02/08/2006 | CN1729978A Freeze dry powdered injection of moxlfloxacin or its salts and preparation process thereof |
| 02/08/2006 | CN1729977A Freeze dry powdered injection of moxfloxacin or its salts and preparation process thereof |
| 02/08/2006 | CN1729973A Kurarinone formulation and its preparation process |
| 02/08/2006 | CN1729968A Orally administered composition containing sodium new houttuyfonate |
| 02/08/2006 | CN1240717C Low-toxicity human interferon-alpha analog |
| 02/08/2006 | CN1240713C New compound |
| 02/08/2006 | CN1240708C New derivatives of erythromycin, process for making them and use as medicaments |
| 02/08/2006 | CN1240707C Z-halo-6-o-substituted ketolide derivatives |
| 02/08/2006 | CN1240706C Process for producing super critical extracting caterpillar fungus deoxynucleoside |
| 02/08/2006 | CN1240700C Aromatic heterocyclic carboxylic acid derivative, preparing method and application in medicine |
| 02/08/2006 | CN1240690C Preparation method and use of sulfalene oxazole derivative |
| 02/08/2006 | CN1240437C Oral administered self-emulsifying formulations of pyranone proteinase inhibitors |
| 02/08/2006 | CN1240409C Medicine for treating chronic hepatitis |
| 02/08/2006 | CN1240404C Chinese herbal medicine prescription for prevention and treatment of atypical pneumonia |
| 02/08/2006 | CN1240386C Matrix metal proteinase and tumor necrosis inhibitor |
| 02/07/2006 | US6996473 Method for screening and producing compound libraries |
| 02/07/2006 | US6995297 diapers comprising pads made of mixtures of plant extracts and pulps; skin disorders |
| 02/07/2006 | US6995283 Benzophenones as inhibitors of reverse transcriptase |
| 02/07/2006 | US6995272 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 02/07/2006 | US6995184 Such as (7-chloro-2-methyl-1-(3-(methylsulphanyl)propyl)-1H-indol-3-yl)(2,3-dichloro-phenyl)methanone; cannabinoid receptors (cb2); G proteins coupled receptors |
| 02/07/2006 | US6995182 1-sulfonyl pyrrolidine derivatives |
| 02/07/2006 | US6995177 HCV NS3 protease inhibitors |
| 02/07/2006 | US6995174 for inhibiting proteases |
| 02/07/2006 | US6995170 formed by reacting 7-halogeno-8-cyano-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid with (1S,6S)-2,8-diazabicyclo[4.3.0]nonane in presence of base/diluent; for use as antibacterial agent |
| 02/07/2006 | US6995144 for example, 6-[2-[4-(2-fluorophenoxymethyl)piperidino]ethyl]-1H-pyrazin-2-one; therapeutic or prophylactic agent for diabetic neuralgia, HIV neuralgia, postherpetic neuralgia, nerve system disorders |
| 02/07/2006 | US6995143 Therapy against antibiotic resistance infections |
| 02/07/2006 | US6995142 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 02/07/2006 | US6995139 Cyclic undecapeptide pro-drugs and uses thereof |
| 02/07/2006 | US6995138 Cross-linked glycopeptide-cephalosporin antibiotics |
| 02/07/2006 | US6995133 invention describes reduced synthesis of IFN alpha 5 in livers of patients with hepatitis C in comparison to healthy livers; demonstrates importance of use of such interferon sub-types in fabricating compositions for treating viral hepatopathies |
| 02/07/2006 | US6994957 Using nucleic acid |
| 02/07/2006 | US6994863 Pharmaceutical and cosmetic carrier and composition for topical application |
| 02/07/2006 | US6994860 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 02/07/2006 | US6994859 Biologically active, hemagglutinin from type A Clostridium botulinum and methods of use |
| 02/07/2006 | US6994857 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 02/07/2006 | US6994854 Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections |